` M7T (Mach7 Technologies Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

M7T
vs
S&P/ASX 300

Over the past 12 months, M7T has underperformed S&P/ASX 300, delivering a return of -47% compared to the S&P/ASX 300's 10% growth.

Stocks Performance
M7T vs S&P/ASX 300

Loading
M7T
S&P/ASX 300
Add Stock
www.alphaspread.com

Performance Gap
M7T vs S&P/ASX 300

Loading
M7T
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
M7T vs S&P/ASX 300

Loading
M7T
S&P/ASX 300
Add Stock

Competitors Performance
Mach7 Technologies Ltd vs Peers

S&P/ASX 300
M7T
VEEV
PME
DOCS
2413
Add Stock

Mach7 Technologies Ltd
Glance View

Market Cap
83.2m AUD
Industry
Health Care

Mach7 Technologies Ltd. provides medical imaging software and services for healthcare institutions. The company is headquartered in Melbourne, Victoria and currently employs 90 full-time employees. The company went IPO on 2005-11-30. The principal activities of the Company include the provision of enterprise imaging data sharing, storage and interoperability for healthcare enterprises globally. The firm operates through two segments: sale of software and rendering of professional services. The sale of software segment engaged in selling software licenses. The provision of the software license is a distinct performance obligation as the customer can derive substantial benefits from the license on its own when the license is delivered and installed. Healthcare enterprises globally segment engaged in providing professional services, such as implementation, training and annual support services. The firm provides various solutions, including Enterprise Diagnostic Viewing, Enterprise Data Management and Enterprise PACS.

M7T Intrinsic Value
0.446 AUD
Undervaluation 23%
Intrinsic Value
Price
Back to Top